Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice

Bibliographic Information
Authors: Abd Allah M.H.; Zaalouk T.K.; Abo-Sheishaa G.A.; Shalash I.R.; Bayoumy A.S.
Journal: The Egyptian journal of immunology
Publisher: NLM (Medline)
Publication Date: 1 October 2022
Volume / Issue: Volume 29 / Issue 4
Pages: 174–183
ISSN: 11104902
DOI: 10.55133/eji.290417
Scopus: View on Scopus
PubMed: 36208046
Document Type: Article
Access: All Open Access; Bronze Open Access
Authors and Affiliations
Abd Allah M.H., Department of Medical Parasitology Faculty of Medicine, Al-Azhar University, Cairo, Egypt; Zaalouk T.K., Department of Medical Parasitology Faculty of Medicine, Al-Azhar University, Cairo, Egypt; Abo-Sheishaa G.A., Department of Medical Parasitology Faculty of Medicine, Al-Azhar University, Cairo, Egypt; Shalash I.R., Department of Medical Parasitology, Theodor Bilharz Research Institute, Giza, Egypt; Bayoumy A.S., Department of Medical Parasitology Faculty of Medicine, Al-Azhar University, Cairo, Egypt
Abstract
Schistosoma mansoni liver fibrosis is a complicated multicellular process involving numerous cytokines, chemokines, and growth factors. Transforming growth factor beta 1 (TGF- 1) and interleukin (IL)-13 have been identified as critical pro-fibrotic mediators in many studies. IL-17A was linked to enhanced TGF- and IL-13-induced pathologies. This case-control study aimed to explore the effect of IL-17A on TGF- and IL-13-induced liver fibrosis during experimentally schistosomiasis mansoni infection. A total of 40 laboratory-bred female C57BL/6 mice were divided into four equal groups (G), G1 non-infected, G2 infected wild type (WT), G3 infected/anti-IL-17 monoclonal antibodies (mAb) and G4 treated mice. Mice were infected percutaneously with 40±5 cercariae per mouse. Neutralizing IL-17 mAb was administered to G3 intraperitoneally 3 weeks after infection and then every third day until 2 days before sacrification; mice of G4 were treated with a single dose of praziquantel. Serum levels of TGF- , IL-13, IL-17A, and proinflammatory cytokines were measured by ELISA. Liver granulomas were identified by hematoxylin-eosin stain and measured by an ocular micrometer. There was a significantly increased serum concentration of TGF- , IL-13, and IL-17A in infected WT mice (P<0.01), but praziquantel treatment reduced cytokine levels (P<0.03). Neutralization of IL-17A activity remarkably reduced serum concentrations of TGF- and IL-13 (P <0.03) resulting in improved liver functions and reduced granuloma size. Secretion of IL- IL-6 and TNF- were markedly enhanced by infection, however, mice that received anti-mouse IL-17 mAb displayed fewer inflammatory mediators (P<0.03). In conclusion, IL-17A might contribute to the progress of liver fibrosis by enhancing the profibrotic effect of TGF- and IL-13 in mice infected with S. mansoni. Copyright© by the Egyptian Association of Immunologists.
Citation Information
Scopus Citations: 9
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
